Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Micallef · SciRah

Researcher profile · Semantic Scholar

I. Micallef

Share profile

I. Micallef — researcher profile on SciRah

h-index: 24
Works: 80
Citations: 3,021

Most-cited papers

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.
G. Nowakowski, B. Laplant, W. Macon, C. Reeder +12 more
2015Journal of Clinical Oncology352 citations
Semantic Scholar
A Phase II Trial of the Oral mTOR Inhibitor Everolimus in Relapsed Aggressive Lymphoma
T. Witzig, C. Reeder, B. Laplant, Mamta Gupta +8 more
2010Leukemia316 citations Open access
Semantic Scholar
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.
L. Porrata, M. Gertz, D. Inwards, M. Litzow +8 more
2001Blood279 citations Open access
Semantic Scholar
A Phase II Trial of The Oral Mtor Inhibitor Everolimus in Relapsed Hodgkin Lymphoma
P. Johnston, D. Inwards, J. Colgan, B. Laplant +8 more
2010American journal of hematology/oncology221 citations Open access
Semantic Scholar
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
R. Wilcox, K. Ristow, T. Habermann, D. Inwards +8 more
2011Leukemia194 citations Open access
Semantic Scholar
Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.
C. Thompson, H. Ghesquières, M. Maurer, J. Cerhan +17 more
2014Journal of Clinical Oncology163 citations Open access
Semantic Scholar
Bowel perforation in intestinal lymphoma: incidence and clinical features.
Rakhee Vaidya, T. Habermann, J. Donohue, K. Ristow +12 more
2013Annals of Oncology161 citations Open access
Semantic Scholar
The Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) with Everolimus Results in Clinical Responses and Mobilization of CLL Cells into the Circulation
C. Zent, B. Laplant, P. Johnston, T. Call +3 more
2010Cancer120 citations Open access
Semantic Scholar
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.
I. Micallef, Matthew J. Maurer, G. Wiseman, D. Nikcevich +7 more
2011Blood116 citations Open access
Semantic Scholar
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study
G. Nowakowski, B. Laplant, T. Habermann, C. Rivera +9 more
2011Leukemia101 citations Open access
Semantic Scholar
Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma
Cristina João, L. Porrata, D. Inwards, S. Ansell +4 more
2006Bone Marrow Transplantation83 citations Open access
Semantic Scholar
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
A. Dispenzieri, K. Seenithamby, M. Lacy, Shaji K. Kumar +13 more
2013Bone Marrow Transplantation80 citations Open access
Semantic Scholar
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
M. Elliott, A. Tefferi, W. Hogan, L. Letendre +10 more
2006Bone Marrow Transplantation71 citations Open access
Semantic Scholar
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte‐predominant Hodgkin lymphoma
L. Porrata, K. Ristow, T. Habermann, T. Witzig +8 more
2012British Journal of Haematology67 citations
Semantic Scholar
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma
L. Porrata, K. Rsitow, D. Inwards, S. Ansell +8 more
2010Leukemia62 citations Open access
Semantic Scholar
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma
R. Howe, I. Micallef, D. Inwards, S. Ansell +9 more
2003Bone Marrow Transplantation60 citations
Semantic Scholar
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma
F. Buadi, I. Micallef, S. Ansell, L. Porrata +8 more
2006Bone Marrow Transplantation56 citations Open access
Semantic Scholar
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19
R. Razonable, Nicole C.E. Aloia, Ryan J. Anderson, G. Anil +66 more
2021Mayo Clinic proceedings50 citations Open access
Semantic Scholar
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
A. Dispenzieri, G. Wiseman, M. Lacy, M. Litzow +16 more
2005Leukemia48 citations Open access
Semantic Scholar
Food-Frequency Questionnaire Based Estimates of Total Antioxidant Capacity and Risk of Non-Hodgkin Lymphoma
S. Holtan, Helen M. O'Connor, Z. Fredericksen, Mark Liebow +8 more
2011International Journal of Cancer40 citations Open access
Semantic Scholar
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma
Sanjal H. Desai, M. Spinner, K. David, V. Bachanova +26 more
2023American journal of hematology/oncology35 citations Open access
Semantic Scholar
Safety and Efficacy of Upfront Plerixafor + G-CSF vs. Placebo + G-CSF for Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients ≥60 and <60 Years of Age with Non-Hodgkin’s Lymphoma or Multiple Myeloma
I. Micallef, Pat Stiff, E. Stadtmauer, B. Bolwell +5 more
2013American journal of hematology/oncology35 citations Open access
Semantic Scholar
Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma
Sean I Tracy, M. Maurer, T. Witzig, Matthew M Drake +13 more
2017Blood Cancer Journal33 citations Open access
Semantic Scholar
High‐dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis
I. Ghobrial, F. Buadi, R. Spinner, J. Colgan +5 more
2004Cancer32 citations
Semantic Scholar
A Phase II Trial of R-CHOP Followed by Radioimmunotherapy for Early Stage (Stages I/II) Diffuse Large B-Cell Non-Hodgkin Lymphoma: ECOG3402
T. Witzig, F. Hong, I. Micallef, R. Gascoyne +5 more
2015British Journal of Haematology23 citations Open access
Semantic Scholar
Ibritumomab tiuxetan for non-Hodgkin’s lymphoma
Patrick B. Johnston, Cara Bondly, I. Micallef
2006Expert Review of Anticancer Therapy23 citations
Semantic Scholar
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes
Charlotte B Wagner, K. Boucher, A. Nedved, I. Micallef +26 more
2023Haematologica19 citations Open access
Semantic Scholar
Response to Drs Marks and Bird
Patrick B. Johnston, G. Wiseman, I. Micallef
2008Bone Marrow Transplantation19 citations Open access
Semantic Scholar
Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation
A. Kansagra, D. Inwards, S. Ansell, I. Micallef +4 more
2018Bone Marrow Transplantation17 citations
Semantic Scholar
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience
Steven R. Hwang, R. Godby, B. Negaard, Raphael Mwangi +11 more
2024Blood Advances15 citations Open access
Semantic Scholar
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies
S. Sinha, M. Gertz, M. Lacy, A. Dispenzieri +8 more
2012Leukemia15 citations Open access
Semantic Scholar
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies
S. Holtan, W. Hogan, M. Elliott, S. Ansell +7 more
2010Bone Marrow Transplantation15 citations Open access
Semantic Scholar
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma.
Sanjal H. Desai, A. Moskowitz, R. Merryman, H. Shah +20 more
2025Blood12 citations Open access
Semantic Scholar
A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
A. Dispenzieri, Anita D'Souza, M. Gertz, K. Laumann +16 more
2017Bone Marrow Transplantation11 citations
Semantic Scholar
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy
A. Tun, Yucai Wang, S. Maliske, I. Micallef +11 more
2024Haematologica10 citations Open access
Semantic Scholar
Neurologic Clinical, Electrophysiologic, and Pathologic Characteristics of Primary vs Secondary Neurolymphomatosis
Michael P. Skolka, N. Suanprasert, Jennifer M. Martinez-Thompson, Rebecca L. King +12 more
2024Neurology10 citations
Semantic Scholar
Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma
Huong L. Truong, Jason N. Barreto, Kristin C. Mara, P. Hampel +8 more
2024JCO Oncology Practice9 citations
Semantic Scholar
Efficacy of pembrolizumab monotherapy and in combination with BCR inhibitors for Richter transformation of chronic lymphocytic leukemia (CLL).
Yu-Cai Wang, B. Laplant, S. Parikh, J. Leis +16 more
2024Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
Sanjal H. Desai, M. Spinner, A. Evens, A. Sýkorová +30 more
2023Blood Advances9 citations Open access
Semantic Scholar
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization
Harris V. K. Naina, R. Pruthi, D. Inwards, D. Dingli +14 more
2011Bone Marrow Transplantation8 citations
Semantic Scholar
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy
J. Burlile, K. Frechette, W. Breen, Steven R. Hwang +17 more
2024Blood Advances7 citations Open access
Semantic Scholar
Combination of lenalidomide with R-CHOP (R2CHOP) as an initial therapy for aggressive B-cell lymphomas: A phase I/II study.
G. Nowakowski, C. Reeder, B. Laplant, T. Habermann +8 more
2011Journal of Clinical Oncology7 citations
Semantic Scholar
Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study
B. Dhakal, Meiyu Zhang, L. Burns, Xiao-Ying Tang +19 more
2023Haematologica6 citations Open access
Semantic Scholar
Autologous stem cell transplant in fit patients with late relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.
A. Tun, Yu-Cai Wang, S. Maliske, I. Micallef +11 more
2024Transplantation and Cellular Therapy5 citations Open access
Semantic Scholar
Day 100 Natural Killer Cell/CD14+HLA‐DRDIM ratio and survival in lymphoma post‐autologous peripheral blood hematopoietic stem cell transplantation
L. Porrata, S. Ansell, I. Micallef, Patrick B. Johnston +4 more
2023Clinical Transplantation3 citations Open access
Semantic Scholar
Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant
A. Tun, Yucai Wang, A. Matin, D. Inwards +12 more
2023HemaSphere3 citations Open access
Semantic Scholar
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
Robert M. Kraft, S. Ansell, J. Villasboas, N. Bennani +12 more
2021Journal of Clinical Oncology3 citations
Semantic Scholar
CLINICAL FEATURES, TREATMENT AND OUTCOME OF NEUROLYMPHOMATOSIS: SINGLE INSTITUTION EXPERIENCE
M. Novo, G. Nowakowski, I. Micallef, K. Ristow +2 more
2019Hematological Oncology3 citations Open access
Semantic Scholar
Central nervous system crystal‐storing histiocytosis: A case report and literature review
N. Nathoo, Daniel P. Larson, Yong Guo, C. Giannini +8 more
2024European Journal of Neurology2 citations Open access
Semantic Scholar
End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
Karan L. Chohan, J. Young, S. Lester, M. Moustafa +7 more
2022Haematologica2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Inwards×26
Invite
D. Inwards — researcher profile on SciRah
S. Ansell×23
Invite
S. Ansell — researcher profile on SciRah
L. Porrata×22
Invite
L. Porrata — researcher profile on SciRah
Patrick B. Johnston×20
Invite
Patrick B. Johnston — researcher profile on SciRah

×16

Invite

G. Nowakowski — researcher profile on SciRah

T. Habermann×15

Invite

T. Habermann — researcher profile on SciRah

Invite

T. Witzig — researcher profile on SciRah

Invite

T. Witzig — researcher profile on SciRah

Invite

M. Lacy — researcher profile on SciRah

Invite

P. Johnston — researcher profile on SciRah

D. Gastineau×9

Invite

D. Gastineau — researcher profile on SciRah

A. Dispenzieri×9

Invite

A. Dispenzieri — researcher profile on SciRah